PAVE Act

HR 9778, the PAVE Act, requires Medicare to include penicillin allergy verification during routine preventive exams and annual wellness visits for seniors aged 65 and older. The bill mandates identifying patients with self-reported penicillin allergies, assessing whether their history indicates a true allergy, explaining the health risks of a false label, and referring to specialists when needed. This applies to Medicare-covered visits starting January 1, 2025, directly affecting seniors with penicillin allergy labels in their medical records. The goal is to correct false allergies - supported by evidence showing over 90% of such labels are inaccurate - improving treatment options and reducing unnecessary healthcare costs.